Click for best price
Cancer Gene Therapy Market Size, Share 2024
| Market size in 2023 |
US$ 492.3 million
|
Forecast Market size by 2030 |
US$ 1638.2 million
|
| Growth Rate |
CAGR of 18.7% |
Number of Pages |
104 Pages |
The global Cancer Gene Therapy market was valued at US$ 492.3 million in 2023 and is projected to reach US$ 1638.2 million by 2030, at a CAGR of 18.7% during the forecast period.
The USA market for Global Cancer Gene Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Cancer Gene Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Cancer Gene Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Cancer Gene Therapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer Gene Therapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer Gene Therapy, challenges faced by the industry, and potential opportunities for market players.
The global Cancer Gene Therapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer Gene Therapy market presents opportunities for various stakeholders, including Hospitals, Diagnostics Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer Gene Therapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Cancer Gene Therapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer Gene Therapy market.
Market Overview: The report provides a comprehensive overview of the Cancer Gene Therapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oncolytic Virotherapy, Gene Transfer), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer Gene Therapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer Gene Therapy market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer Gene Therapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer Gene Therapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer Gene Therapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer Gene Therapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer Gene Therapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer Gene Therapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Oncolytic Virotherapy
- Gene Transfer
- Gene-Induced Immunotherapy
Market segment by Application
- Hospitals
- Diagnostics Centers
- Research Institutes
Global Cancer Gene Therapy Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Adaptimmune
- Bluebird bio
- Celgene
- Shanghai Sunway Biotech
- Shenzhen SiBiono GeneTech
- SynerGene Therapeutics
- Altor BioScience
- Amgen
- Argenx
- BioCancell
- GlaxoSmithKline
- Merck
- OncoGenex Pharmaceuticals
- Transgene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Gene Therapy, market overview.
Chapter 2: Global Cancer Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Cancer Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Gene Therapy Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 492.3 million
|
| Forecast Market size by 2030 |
US$ 1638.2 million
|
| Growth Rate |
CAGR of 18.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
104 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Gene Therapy Overall Market Size
2.1 Global Cancer Gene Therapy Market Size: 2023 VS 2030
2.2 Global Cancer Gene Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Gene Therapy Players in Global Market
3.2 Top Global Cancer Gene Therapy Companies Ranked by Revenue
3.3 Global Cancer Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Gene Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Gene Therapy Market Size Markets, 2023 & 2030
4.1.2 Oncolytic Virotherapy
4.1.3 Gene Transfer
4.1.4 Gene-Induced Immunotherapy
4.2 By Type - Global Cancer Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Gene Therapy Revenue, 2019-2024
4.2.2 By Type - Global Cancer Gene Therapy Revenue, 2025-2030
4.2.3 By Type - Global Cancer Gene Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Gene Therapy Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Diagnostics Centers
5.1.4 Research Institutes
5.2 By Application - Global Cancer Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Gene Therapy Revenue, 2019-2024
5.2.2 By Application - Global Cancer Gene Therapy Revenue, 2025-2030
5.2.3 By Application - Global Cancer Gene Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Gene Therapy Market Size, 2023 & 2030
6.2 By Region - Global Cancer Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Gene Therapy Revenue, 2019-2024
6.2.2 By Region - Global Cancer Gene Therapy Revenue, 2025-2030
6.2.3 By Region - Global Cancer Gene Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer Gene Therapy Revenue, 2019-2030
6.3.2 US Cancer Gene Therapy Market Size, 2019-2030
6.3.3 Canada Cancer Gene Therapy Market Size, 2019-2030
6.3.4 Mexico Cancer Gene Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Gene Therapy Revenue, 2019-2030
6.4.2 Germany Cancer Gene Therapy Market Size, 2019-2030
6.4.3 France Cancer Gene Therapy Market Size, 2019-2030
6.4.4 U.K. Cancer Gene Therapy Market Size, 2019-2030
6.4.5 Italy Cancer Gene Therapy Market Size, 2019-2030
6.4.6 Russia Cancer Gene Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Cancer Gene Therapy Market Size, 2019-2030
6.4.8 Benelux Cancer Gene Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Gene Therapy Revenue, 2019-2030
6.5.2 China Cancer Gene Therapy Market Size, 2019-2030
6.5.3 Japan Cancer Gene Therapy Market Size, 2019-2030
6.5.4 South Korea Cancer Gene Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Cancer Gene Therapy Market Size, 2019-2030
6.5.6 India Cancer Gene Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer Gene Therapy Revenue, 2019-2030
6.6.2 Brazil Cancer Gene Therapy Market Size, 2019-2030
6.6.3 Argentina Cancer Gene Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Gene Therapy Revenue, 2019-2030
6.7.2 Turkey Cancer Gene Therapy Market Size, 2019-2030
6.7.3 Israel Cancer Gene Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer Gene Therapy Market Size, 2019-2030
6.7.5 UAE Cancer Gene Therapy Market Size, 2019-2030
7 Cancer Gene Therapy Companies Profiles
7.1 Adaptimmune
7.1.1 Adaptimmune Company Summary
7.1.2 Adaptimmune Business Overview
7.1.3 Adaptimmune Cancer Gene Therapy Major Product Offerings
7.1.4 Adaptimmune Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.1.5 Adaptimmune Key News & Latest Developments
7.2 Bluebird bio
7.2.1 Bluebird bio Company Summary
7.2.2 Bluebird bio Business Overview
7.2.3 Bluebird bio Cancer Gene Therapy Major Product Offerings
7.2.4 Bluebird bio Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.2.5 Bluebird bio Key News & Latest Developments
7.3 Celgene
7.3.1 Celgene Company Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Cancer Gene Therapy Major Product Offerings
7.3.4 Celgene Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.3.5 Celgene Key News & Latest Developments
7.4 Shanghai Sunway Biotech
7.4.1 Shanghai Sunway Biotech Company Summary
7.4.2 Shanghai Sunway Biotech Business Overview
7.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Major Product Offerings
7.4.4 Shanghai Sunway Biotech Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.4.5 Shanghai Sunway Biotech Key News & Latest Developments
7.5 Shenzhen SiBiono GeneTech
7.5.1 Shenzhen SiBiono GeneTech Company Summary
7.5.2 Shenzhen SiBiono GeneTech Business Overview
7.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Major Product Offerings
7.5.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.5.5 Shenzhen SiBiono GeneTech Key News & Latest Developments
7.6 SynerGene Therapeutics
7.6.1 SynerGene Therapeutics Company Summary
7.6.2 SynerGene Therapeutics Business Overview
7.6.3 SynerGene Therapeutics Cancer Gene Therapy Major Product Offerings
7.6.4 SynerGene Therapeutics Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.6.5 SynerGene Therapeutics Key News & Latest Developments
7.7 Altor BioScience
7.7.1 Altor BioScience Company Summary
7.7.2 Altor BioScience Business Overview
7.7.3 Altor BioScience Cancer Gene Therapy Major Product Offerings
7.7.4 Altor BioScience Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.7.5 Altor BioScience Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Cancer Gene Therapy Major Product Offerings
7.8.4 Amgen Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.8.5 Amgen Key News & Latest Developments
7.9 Argenx
7.9.1 Argenx Company Summary
7.9.2 Argenx Business Overview
7.9.3 Argenx Cancer Gene Therapy Major Product Offerings
7.9.4 Argenx Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.9.5 Argenx Key News & Latest Developments
7.10 BioCancell
7.10.1 BioCancell Company Summary
7.10.2 BioCancell Business Overview
7.10.3 BioCancell Cancer Gene Therapy Major Product Offerings
7.10.4 BioCancell Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.10.5 BioCancell Key News & Latest Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Cancer Gene Therapy Major Product Offerings
7.11.4 GlaxoSmithKline Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.11.5 GlaxoSmithKline Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Cancer Gene Therapy Major Product Offerings
7.12.4 Merck Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.12.5 Merck Key News & Latest Developments
7.13 OncoGenex Pharmaceuticals
7.13.1 OncoGenex Pharmaceuticals Company Summary
7.13.2 OncoGenex Pharmaceuticals Business Overview
7.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Major Product Offerings
7.13.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.13.5 OncoGenex Pharmaceuticals Key News & Latest Developments
7.14 Transgene
7.14.1 Transgene Company Summary
7.14.2 Transgene Business Overview
7.14.3 Transgene Cancer Gene Therapy Major Product Offerings
7.14.4 Transgene Cancer Gene Therapy Revenue in Global Market (2019-2024)
7.14.5 Transgene Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Cancer Gene Therapy Market Drivers in Global Market
Table 3. Cancer Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Cancer Gene Therapy in Global Market
Table 5. Top Cancer Gene Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cancer Gene Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cancer Gene Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cancer Gene Therapy Product Type
Table 9. List of Global Tier 1 Cancer Gene Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Gene Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer Gene Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cancer Gene Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cancer Gene Therapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cancer Gene Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cancer Gene Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cancer Gene Therapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cancer Gene Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cancer Gene Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cancer Gene Therapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cancer Gene Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cancer Gene Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cancer Gene Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cancer Gene Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cancer Gene Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cancer Gene Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cancer Gene Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cancer Gene Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cancer Gene Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cancer Gene Therapy Revenue, (US$, Mn), 2025-2030
Table 30. Adaptimmune Company Summary
Table 31. Adaptimmune Cancer Gene Therapy Product Offerings
Table 32. Adaptimmune Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Adaptimmune Key News & Latest Developments
Table 34. Bluebird bio Company Summary
Table 35. Bluebird bio Cancer Gene Therapy Product Offerings
Table 36. Bluebird bio Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Bluebird bio Key News & Latest Developments
Table 38. Celgene Company Summary
Table 39. Celgene Cancer Gene Therapy Product Offerings
Table 40. Celgene Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Celgene Key News & Latest Developments
Table 42. Shanghai Sunway Biotech Company Summary
Table 43. Shanghai Sunway Biotech Cancer Gene Therapy Product Offerings
Table 44. Shanghai Sunway Biotech Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Shanghai Sunway Biotech Key News & Latest Developments
Table 46. Shenzhen SiBiono GeneTech Company Summary
Table 47. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Offerings
Table 48. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Shenzhen SiBiono GeneTech Key News & Latest Developments
Table 50. SynerGene Therapeutics Company Summary
Table 51. SynerGene Therapeutics Cancer Gene Therapy Product Offerings
Table 52. SynerGene Therapeutics Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. SynerGene Therapeutics Key News & Latest Developments
Table 54. Altor BioScience Company Summary
Table 55. Altor BioScience Cancer Gene Therapy Product Offerings
Table 56. Altor BioScience Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Altor BioScience Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Cancer Gene Therapy Product Offerings
Table 60. Amgen Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Amgen Key News & Latest Developments
Table 62. Argenx Company Summary
Table 63. Argenx Cancer Gene Therapy Product Offerings
Table 64. Argenx Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Argenx Key News & Latest Developments
Table 66. BioCancell Company Summary
Table 67. BioCancell Cancer Gene Therapy Product Offerings
Table 68. BioCancell Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. BioCancell Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Cancer Gene Therapy Product Offerings
Table 72. GlaxoSmithKline Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Cancer Gene Therapy Product Offerings
Table 76. Merck Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 77. Merck Key News & Latest Developments
Table 78. OncoGenex Pharmaceuticals Company Summary
Table 79. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Offerings
Table 80. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 81. OncoGenex Pharmaceuticals Key News & Latest Developments
Table 82. Transgene Company Summary
Table 83. Transgene Cancer Gene Therapy Product Offerings
Table 84. Transgene Cancer Gene Therapy Revenue (US$, Mn) & (2019-2024)
Table 85. Transgene Key News & Latest Developments
List of Figures
Figure 1. Cancer Gene Therapy Segment by Type in 2023
Figure 2. Cancer Gene Therapy Segment by Application in 2023
Figure 3. Global Cancer Gene Therapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer Gene Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer Gene Therapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2023
Figure 8. By Type - Global Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cancer Gene Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cancer Gene Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 16. US Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 20. Germany Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. France Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 28. China Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. India Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 34. Brazil Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cancer Gene Therapy Revenue Market Share, 2019-2030
Figure 37. Turkey Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cancer Gene Therapy Revenue, (US$, Mn), 2019-2030
Figure 41. Adaptimmune Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bluebird bio Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Celgene Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Shanghai Sunway Biotech Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. SynerGene Therapeutics Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Altor BioScience Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Amgen Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Argenx Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. BioCancell Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. GlaxoSmithKline Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Merck Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Transgene Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
